103 related articles for article (PubMed ID: 11288048)
1. Effect of estrogen on serum DHEA in younger and older women and the relationship of DHEA to adiposity and gender.
Kraemer RR; Synovitz LB; Gimpel T; Kraemer GR; Johnson LG; Castracane VD
Metabolism; 2001 Apr; 50(4):488-93. PubMed ID: 11288048
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone sulfate levels in women. Relationships with body mass index, insulin and glucose levels.
Al-Harithy RN
Saudi Med J; 2003 Aug; 24(8):837-41. PubMed ID: 12939667
[TBL] [Abstract][Full Text] [Related]
3. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin concentration in women: effect of age, obesity, and estrogen administration.
Castracane VD; Kraemer RR; Franken MA; Kraemer GR; Gimpel T
Fertil Steril; 1998 Sep; 70(3):472-7. PubMed ID: 9757875
[TBL] [Abstract][Full Text] [Related]
5. Relationship of leptin concentration to gender, body mass index and age in Saudi adults.
Al-Harithy RN
Saudi Med J; 2004 Aug; 25(8):1086-90. PubMed ID: 15322603
[TBL] [Abstract][Full Text] [Related]
6. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
Pluchino N; Ninni F; Stomati M; Freschi L; Casarosa E; Valentino V; Luisi S; Genazzani AD; Potì E; Genazzani AR
Maturitas; 2008 Apr; 59(4):293-303. PubMed ID: 18394829
[TBL] [Abstract][Full Text] [Related]
7. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
8. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
10. Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use.
O'Brien SN; Anandjiwala J; Price TM
Obstet Gynecol; 1997 Aug; 90(2):244-8. PubMed ID: 9241302
[TBL] [Abstract][Full Text] [Related]
11. Short-term aerobic training and circulatory function in women: age and hormone-replacement therapy.
Katyal S; Freeman M; Miller JA; Thomas SG
Clin Sci (Lond); 2003 Mar; 104(3):267-73. PubMed ID: 12605585
[TBL] [Abstract][Full Text] [Related]
12. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
13. Ageing and plasma adiponectin concentration in apparently healthy males and females.
Adamczak M; Rzepka E; Chudek J; Wiecek A
Clin Endocrinol (Oxf); 2005 Jan; 62(1):114-8. PubMed ID: 15638879
[TBL] [Abstract][Full Text] [Related]
14. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
16. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
17. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
[TBL] [Abstract][Full Text] [Related]
18. [Changes in body weight and the distribution of adipose tissue in hysterectomized postmenopausal patients on estrogen replacement therapy].
Carranza Lira S; Aguado Pérez RA
Ginecol Obstet Mex; 1999 Jul; 67():346-8. PubMed ID: 10496057
[TBL] [Abstract][Full Text] [Related]
19. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
20. [Derivatives of dehydroepiandrosterone and their changes during a one-day starvation test].
Matoulek M; Hampl R; Svacina S; Sulcová J; Haas T
Cas Lek Cesk; 2000 Dec; 139(24):772-5. PubMed ID: 11262916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
